Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011 (2011), Article ID 841346, 8 pages
http://dx.doi.org/10.1155/2011/841346
Research Article

Expression of Proinflammatory and Regulatory Cytokines via NF-κB and MAPK-Dependent and IFN Regulatory Factor-3-Independent Mechanisms in Human Primary Monocytes Infected by Mycobacterium tuberculosis

1Dipartimento di Malattie Infettive, Parassitarie ed Immmuno-mediate, Istituto Superiore di Sanità, I-00161, Rome, Italy
2EA4303 “Inflammation et Immunité de l'épithélium Respiratoire”, IFR53, UFR de Pharmacie, Université de Reims Champagne-Ardenne, 51096 Reims, France

Received 14 October 2010; Accepted 26 November 2010

Academic Editor: James Triccas

Copyright © 2011 Elena Giacomini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, WHO Report 2009: Global Tuberculosis Control, Epidemiology, Strategy, Financing, WHO Press, 2009.
  2. P. G. Lin and J. L. Flynn, “Understanding latent tuberculosis: a moving target,” Journal of Immunology, vol. 185, no. 1, pp. 15–22, 2010. View at Publisher · View at Google Scholar · View at PubMed
  3. A. M. Cooper and S. A. Khader, “The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis,” Immunological Reviews, vol. 226, no. 1, pp. 191–204, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. C. V. Harding and W. H. Boom, “Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors,” Nature Reviews Microbiology, vol. 8, no. 4, pp. 296–307, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. Giacomini, E. Iona, and E. Iona, “Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response,” Journal of Immunology, vol. 166, no. 12, pp. 7033–7041, 2001. View at Google Scholar · View at Scopus
  6. S. H. E. Kaufmann, “How can immunology contribute to the control of tuberculosis?” Nature Reviews Immunology, vol. 1, no. 1, pp. 20–30, 2001. View at Google Scholar · View at Scopus
  7. N. V. Serbina, T. Jia, T. M. Hohl, and E. G. Pamer, “Monocyte-mediated defense against microbial pathogens,” Annual Review of Immunology, vol. 26, pp. 421–452, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. E. Remoli, E. Giacomini, and E. Giacomini, “Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10,” Immunology and Cell Biology. In press. View at Publisher · View at Google Scholar · View at PubMed
  9. M. C. Gagliardi, R. Teloni, and R. Teloni, “Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells,” Infection and Immunity, vol. 77, no. 11, pp. 4947–4952, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. Giacomini, M. E. Remoli, V. Gafa, M. Pardini, L. Fattorini, and E. M. Coccia, “IFN-β improves BCG immunogenicity by acting on DC maturation,” Journal of Leukocyte Biology, vol. 85, no. 3, pp. 462–468, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. E. M. Coccia, M. Severa, and M. Severa, “Viral infection and toll-like receptor agonists induce a differential expression of type I and λ interferons in humans plasmacytoid and monocyte-derived dendritic cells,” European Journal of Immunology, vol. 34, no. 3, pp. 796–805, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. E. Remoli, V. Gafa, E. Giacomini, M. Severa, R. Lande, and E. M. Coccia, “IFN-β modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression,” European Journal of Immunology, vol. 37, no. 12, pp. 3499–3508, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. E. Remoli, E. Giacomini, and E. Giacomini, “Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis,” Journal of Immunology, vol. 169, no. 1, pp. 366–374, 2002. View at Google Scholar · View at Scopus
  14. P. Méndez-Samperio, “Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease,” International Journal of Infectious Diseases, vol. 14, no. 5, pp. e366–e371, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. A. Khader, G. K. Bell, and G. K. Bell, “IL-23 and IL-17 in the establishment of protective pulmonary CD4 T cell responses after vaccination and during Mycobacterium tuberculosis challenge,” Nature Immunology, vol. 8, no. 4, pp. 369–377, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. A. Khader, J. E. Pearl, and J. E. Pearl, “IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available,” Journal of Immunology, vol. 175, no. 2, pp. 788–795, 2005. View at Google Scholar · View at Scopus
  17. H. Yoshida, M. Nakaya, and Y. Miyazaki, “Interleukin 27: a double-edged sword for offense and defense,” Journal of Leukocyte Biology, vol. 86, no. 6, pp. 1295–1303, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. Goriely and M. Goldman, “Interleukin-12 family members and the balance between rejection and tolerance,” Current Opinion in Organ Transplantation, vol. 13, no. 1, pp. 4–9, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Goriely, C. Molle, and C. Molle, “Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation,” Blood, vol. 107, no. 3, pp. 1078–1084, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. J. Hiscott, “Triggering the innate antiviral response through IRF-3 activation,” Journal of Biological Chemistry, vol. 282, no. 21, pp. 15325–15329, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. Koul, T. Herget, B. Klebl, and A. Ullrich, “Interplay between mycobacteria and host signalling pathways,” Nature Reviews Microbiology, vol. 2, no. 3, pp. 189–202, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. S. B. Jung, C. S. Yang, and C. S. Yang, “The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes,” Infection and Immunity, vol. 74, no. 5, pp. 2686–2696, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. B. Van den Blink, N. P. Juffermans, T. Ten Hove, M. J. Schultz, S. J. H. Van Deventer, T. Van der Poll, and M. P. Peppelenbosch, “p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo,” Journal of Immunology, vol. 166, no. 1, pp. 582–587, 2001. View at Google Scholar · View at Scopus
  24. S. B. Jung, C. H. Song, and C. H. Song, “Role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in the secretion of tumor necrosis factor-α and interleukin-10 by the PPD antigen of Mycobacterium tuberculosis,” Journal of Clinical Immunology, vol. 25, no. 5, pp. 482–490, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. A. Khader and A. M. Cooper, “IL-23 and IL-17 in tuberculosis,” Cytokine, vol. 41, no. 2, pp. 79–83, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. J. Campbell, C. J. Ciesielski, and C. J. Ciesielski, “A novel mechanism for TNF-α regulation by p38 MAPK: involvement of NF-κB with implications for therapy in rheumatoid arthritis,” Journal of Immunology, vol. 173, no. 11, pp. 6928–6937, 2004. View at Google Scholar · View at Scopus
  27. E. van de Vosse, J. T. van Dissel, and T. H. Ottenhoff, “Genetic deficiencies of innate immune signalling in human infectious disease,” The Lancet Infectious Diseases, vol. 9, no. 11, pp. 688–698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Hölscher, A. Hölscher, and A. Hölscher, “The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis,” Journal of Immunology, vol. 174, no. 6, pp. 3534–3544, 2005. View at Google Scholar · View at Scopus
  29. C. M. Robinson and G. J. Nau, “Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis,” Journal of Infectious Diseases, vol. 198, no. 3, pp. 359–366, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. B. Martin, K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen, “Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals,” Immunity, vol. 31, no. 2, pp. 321–330, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. E. Torrado and A. M. Cooper, “IL-17 and Th17 cells in tuberculosis,” Cytokine and Growth Factor Reviews, vol. 21, no. 6, pp. 455–462, 2010. View at Publisher · View at Google Scholar · View at PubMed